Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics

Gritstone Oncology, Inc. (GRTS): $0.74

0.01 (-0.93%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add GRTS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#203 of 360

in industry

GRTS Price/Volume Stats

Current price $0.74 52-week high $3.33
Prev. close $0.75 52-week low $0.67
Day low $0.72 Volume 2,409,650
Day high $0.78 Avg. volume 2,844,679
50-day MA $1.93 Dividend yield N/A
200-day MA $1.92 Market Cap 72.43M

GRTS Stock Price Chart Interactive Chart >


Gritstone Oncology, Inc. (GRTS) Company Bio


Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.


GRTS Latest News Stream


Event/Time News Detail
Loading, please wait...

GRTS Latest Social Stream


Loading social stream, please wait...

View Full GRTS Social Stream

Latest GRTS News From Around the Web

Below are the latest news stories about GRITSTONE BIO INC that investors may wish to consider to help them evaluate GRTS as an investment opportunity.

Forecast: Analysts Think Gritstone bio, Inc.'s (NASDAQ:GRTS) Business Prospects Have Improved Drastically

Celebrations may be in order for Gritstone bio, Inc. ( NASDAQ:GRTS ) shareholders, with the analysts delivering a...

Yahoo | December 13, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the Compensation Committee of the company’s Board of Directors granted four employees nonqualified stock options to purchase an aggregate of 42,000 shares of its common stock with an exercise price of $1.53, which is equal to the closing price of Gritstone’s common stock on December 1, 2023, th

Yahoo | December 7, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor conferences: 6th Annual Evercore ISI HealthCONx Conference (Fireside Chat)Presentation Date and Time: Wednesday, November 29, 2023 at 10:00am ETSpeaker: Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive OfficerLocation:

Yahoo | November 20, 2023

Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development

Advancements in COVID-19 and Cancer Vaccine Programs Amid Increased R&D Spending

Yahoo | November 8, 2023

Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

-- BARDA contract and IDWeek presentations position Gritstone’s self-amplifying mRNA (samRNA) as a leading next-generation approach to COVID-19 prevention; preparations underway for Phase 2b head-to-head study evaluating samRNA candidate versus an approved COVID-19 vaccine -- -- Preliminary data from Phase 2 portion of Phase 2/3 study evaluating Gritstone’s personalized cancer vaccine (PCV), GRANITE, in first-line metastatic, microsatellite stable colorectal cancer (MSS-CRC) remain expected in 1

Yahoo | November 8, 2023

Read More 'GRTS' Stories Here

GRTS Price Returns

1-mo -72.99%
3-mo -73.19%
6-mo -62.05%
1-year -71.32%
3-year -91.97%
5-year -93.09%
YTD -63.73%
2023 -40.87%
2022 -73.17%
2021 226.40%
2020 -56.08%
2019 -41.94%

Continue Researching GRTS

Here are a few links from around the web to help you further your research on Gritstone Oncology Inc's stock as an investment opportunity:

Gritstone Oncology Inc (GRTS) Stock Price | Nasdaq
Gritstone Oncology Inc (GRTS) Stock Quote, History and News - Yahoo Finance
Gritstone Oncology Inc (GRTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!